Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives [Corrigendum]
Edis Z, Wang J, Waqas MK, Ijaz M, Ijaz M. Int J Nanomedicine. 2021;16:1313–1330. The authors have advised affiliation 3 on page 1313 is incorrect. The text “Affiliated Hospital of Youjiang Medical College for Nationalities” should read “Affiliated Hospital of...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/4cd834eb3e1941f18d62d0f7ca853c1a |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | Edis Z, Wang J, Waqas MK, Ijaz M, Ijaz M. Int J Nanomedicine. 2021;16:1313–1330.
The authors have advised affiliation 3 on page 1313 is incorrect. The text “Affiliated Hospital of Youjiang Medical College for Nationalities” should read “Affiliated Hospital of Youjiang Medical University for Nationalities”.
The authors apologize for this error.
Read the original article |
|---|